350 related articles for article (PubMed ID: 16807328)
1. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
Dickey CA; Yue M; Lin WL; Dickson DW; Dunmore JH; Lee WC; Zehr C; West G; Cao S; Clark AM; Caldwell GA; Caldwell KA; Eckman C; Patterson C; Hutton M; Petrucelli L
J Neurosci; 2006 Jun; 26(26):6985-96. PubMed ID: 16807328
[TBL] [Abstract][Full Text] [Related]
2. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes.
Saidi LJ; Polydoro M; Kay KR; Sanchez L; Mandelkow EM; Hyman BT; Spires-Jones TL
J Alzheimers Dis; 2015; 44(3):937-47. PubMed ID: 25374103
[TBL] [Abstract][Full Text] [Related]
3. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
[TBL] [Abstract][Full Text] [Related]
4. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
Petrucelli L; Dickson D; Kehoe K; Taylor J; Snyder H; Grover A; De Lucia M; McGowan E; Lewis J; Prihar G; Kim J; Dillmann WH; Browne SE; Hall A; Voellmy R; Tsuboi Y; Dawson TM; Wolozin B; Hardy J; Hutton M
Hum Mol Genet; 2004 Apr; 13(7):703-14. PubMed ID: 14962978
[TBL] [Abstract][Full Text] [Related]
5. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
Shimura H; Schwartz D; Gygi SP; Kosik KS
J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
[TBL] [Abstract][Full Text] [Related]
7. Caspase activation precedes and leads to tangles.
de Calignon A; Fox LM; Pitstick R; Carlson GA; Bacskai BJ; Spires-Jones TL; Hyman BT
Nature; 2010 Apr; 464(7292):1201-4. PubMed ID: 20357768
[TBL] [Abstract][Full Text] [Related]
8. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
9. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice.
Rodríguez-Navarro JA; Gómez A; Rodal I; Perucho J; Martinez A; Furió V; Ampuero I; Casarejos MJ; Solano RM; de Yébenes JG; Mena MA
Hum Mol Genet; 2008 Oct; 17(20):3128-43. PubMed ID: 18640988
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
[TBL] [Abstract][Full Text] [Related]
11. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
[TBL] [Abstract][Full Text] [Related]
12. The role of caspase cleavage of tau in Alzheimer disease neuropathology.
Cotman CW; Poon WW; Rissman RA; Blurton-Jones M
J Neuropathol Exp Neurol; 2005 Feb; 64(2):104-12. PubMed ID: 15751224
[TBL] [Abstract][Full Text] [Related]
13. Dual truncation of tau by caspase-2 accelerates its CHIP-mediated degradation.
Reinhardt L; Musacchio F; Bichmann M; Behrendt A; Ercan-Herbst E; Stein J; Becher I; Haberkant P; Mader J; Schöndorf DC; Schmitt M; Korffmann J; Reinhardt P; Pohl C; Savitski M; Klein C; Gasparini L; Fuhrmann M; Ehrnhoefer DE
Neurobiol Dis; 2023 Jun; 182():106126. PubMed ID: 37086756
[TBL] [Abstract][Full Text] [Related]
14. NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.
Colton CA; Vitek MP; Wink DA; Xu Q; Cantillana V; Previti ML; Van Nostrand WE; Weinberg JB; Dawson H
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12867-72. PubMed ID: 16908860
[TBL] [Abstract][Full Text] [Related]
15. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells.
Arnaud LT; Myeku N; Figueiredo-Pereira ME
J Neurochem; 2009 Jul; 110(1):328-42. PubMed ID: 19457109
[TBL] [Abstract][Full Text] [Related]
16. Akt and CHIP coregulate tau degradation through coordinated interactions.
Dickey CA; Koren J; Zhang YJ; Xu YF; Jinwal UK; Birnbaum MJ; Monks B; Sun M; Cheng JQ; Patterson C; Bailey RM; Dunmore J; Soresh S; Leon C; Morgan D; Petrucelli L
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3622-7. PubMed ID: 18292230
[TBL] [Abstract][Full Text] [Related]
17. Different tau epitopes define Abeta42-mediated tau insolubility.
Pennanen L; Götz J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1097-101. PubMed ID: 16226718
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Protects Optic Nerve Head Astrocytes from Oxidative Stress-Induced Cell Death by Preventing Caspase-3 Activation, Tau Dephosphorylation at Ser
Means JC; Lopez AA; Koulen P
Cell Mol Neurobiol; 2020 Aug; 40(6):911-926. PubMed ID: 31919747
[TBL] [Abstract][Full Text] [Related]
19. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
[TBL] [Abstract][Full Text] [Related]
20. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease.
Noble W; Garwood C; Stephenson J; Kinsey AM; Hanger DP; Anderton BH
FASEB J; 2009 Mar; 23(3):739-50. PubMed ID: 19001528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
